Tevatiapine XR 50mg Quetiapine Fumarate Extended Release Tablets｜其他商品

Tevatiapine XR 50mg Quetiapine Fumarate Extended Release TabletsTevatiapine XR is a pharmaceutical product designed to address chemical imbalances in the brain, offering relief for conditions such as bipolar disorder, major depressive disorder, generalized anxiety disorder, and schizophrenia. This extended-release formulation ensures a steady release of the active ingredient, quetiapine fumarate, enhancing therapeutic efficacy and patient compliance.Key Features
Active Ingredient Quetiapine Fumarate
Extended Release for Sustained Effect
Indicated for Bipolar Disorder, Schizophrenia, and Depression
Technical Specifications
Strength 50mg
Formulation Extended Release Tablet
Application or Use CaseTevatiapine XR is primarily used in the management of psychiatric conditions, providing a reliable option for patients requiring long-term treatment.Typical User/Industry ProfileHealthcare providers specializing in psychiatry and mental health, as well as patients diagnosed with the aforementioned conditions.
.pdp-description-table{width:100%;}.pdp-table-tr{display:flex;justify-content:space-between;}.pdp-table-td{padding:12px 16px;text-align:left;border:none;}.pdp-table-td:first-child{font-weight:bold;width:30%;}.pdp-table-td:nth-child(2){width:70%;}
Brand:Teva Pharma AustraliaCategory:AntipsychoticsSKU:PHA18771Tags:Antipsychotic, Bipolar Disorder, Depression, Extended Release, mcenter, Pharma, Quetiapine, Schizophrenia, XR